Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Anatomic Pathology Board Review > Specific molecular characteristics of Tumors (not soft tissue) > Flashcards

Specific molecular characteristics of Tumors (not soft tissue) Flashcards

1
Q

NR4A3 fusion/activation

A

Acinic Cell Carcinoma
*also DOG1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The majority of cases have t(4,9) resulting in NR4A3 upregulation

A

Acinic Cell Carcinoma
*also DOG1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

t(4;9)

A

Acinic Cell Carcinoma
*also DOG1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Salivary gland; acinic cell carcinoma; molecular

A

The majority of cases have t(4,9) resulting in NR4A3 upregulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Secretory Carcinoma

A

secretory carcinoma harbor ETV6::NTRK3 fusion
t(12;15)(p13;q25)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Salivary gland; secretory carcinoma; molecular

A

secretory carcinoma harbor ETV6::NTRK3 fusion
t(12;15)(p13;q25)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CRTC1::MAML2 fusion is seen in 40-90% of….

A

mucoepidermoid carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

mucoepidermoid carcinoma; molecular

A

CRTC1::MAML2 fusion is seen in 40-90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MYB fusion /activation is seen in 80% of…

A

adenoid cystic carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

adenoid cystic carcinoma; molecular

A

MYB fusion /activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Gains (especially trisomy) of chromosome 7, 17 and loss of Y chromosome

A

Papillary RCC (foam cells, look for tubulopapillary features)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Papillary or tubule-papillary architecture, lined by cuboidal cells (low-grade tumors); cells can have abundant basophilic, eosinophilic, clear +/- cytoplasm, hemosiderin pigment –> FOAM CELLS

A

Papillary RCC (2nd most common RCC)
Gains of chromosome 7, 17 and loss of Y chromosome,
*while majority unilateral, these of all RCCs are most inclined to be b/l and multifocal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Stains for Papillary RCC

A
  • IHC: Positive: PAX8, CK7 (but negative in eosinophilic tumors), AMACR, vimentin, CD10, FH; Negative: CAIX (can be focal positive)
  • Gains of chromosome 7, 17 and loss of Y chromosome,
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MET germline mutation and kidney

A

Papillary RCC
don’t forget the Gains of chromosome 7, 17 and loss of Y chromosome,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

t(6;9)(q22-23;p23-24) …salivary gland….

A

Adenoid Cystic Carcinoma
MYBL1-NFIB fusion → t(6;9)(q22-23;p23-24)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

PLAG1-HMGA2 fusion…

A

pleomorphic adenoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

PAX8/PPAR gamma rearrangement, a translocation (2;3)(q13;p25)

A

This is the second most common mutation found in follicular carcinomas, being present in approximately 30% of follicular carcinomas and approximately 5% of oncocytic (Hurthle cell) carcinomas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Thyroid and RAS mutations

A

These are the most common somatic mutations found in follicular thyroid carcinoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

RET/PTC1 and PTC3 rearrangements on chromosome 10 (10q11. 2)

A

This is the second most common molecular abnormality seen in papillary thyroid carcinomas (PTC), being present in approximately 20% of cases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

TRK rearrangement of the NTRK1 gene of chromosome 1q22

A

This rearrangement is found in less than 5% of PTCs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Thyroid and BRAF.
Point mutation in the BRAF gene at codon 600 (BRAFT1799A [V600E])

A

BRAF mutations are the most commonly detected abnormality in PTC, present in around 45% of adult cases. Ninety percent of these mutations show Valine to Glutamate point mutation BRAFT1799A (V600E).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

granulomatous stuff on cytology of a lymph node…

A

If not medical…
Squamous cell carcinoma, seminoma, and thymoma are the most common metastatic tumors associated with granuloma formation in lymph nodes. Granulomas may also be found in lymph nodes harboring primary or secondary malignant diseases, including Hodgkin lymphoma and T cell-type non-Hodgkin lymphoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Molecular analysis often shows mutations of SMAD4 and KRAS genes

A

KRAS mutations are present in 95% of pancreatic adenocarcinomas. Mutation of SMAD4 (DPC4) is also seen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Atrial myxoma has been linked to which gene?

A

Atrial myxoma has been linked to the PRKAR1-alpha gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

80% of SPORADIC colorectal carcinomas have what mutation?

A

APC.
This is why a germline mutation in APC has 100% chance of colon cancer
*normally, APC product inhibits WNT pathway (B-catenin)
*a mutation of APC will result in abnormal B-catenin nuclear localization
*this is the CHROMOSOMAL instability pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

10-15% of SPORADIC colorectal carcinomas are NOT related to some APC mutation…which mutations are these carrying?

A

somewhere in the hMLH1 realm
*95% are MLH1
*more rarely seen are MSH2 and MSH6
MOST rare: PMS2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

If you lose MLH1 by IHC, what does that mean?

A

*you have more work to do
*MLH1 loss alone (and then it’s dimer) can happen in sporadic tumors
*MSH2, MSH6 and PMS2 loss are essentially lynch diagnostic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

If you lose MSH2, MSH6 orPMS2, what does that mean?

A

*MSH2, MSH6 and PMS2 loss are essentially lynch diagnostic
*MLH1 loss alone (and then it’s dimer) can happen in sporadic tumors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

KRAS mutations in a colorectal carcinoma…

A

EGFR-targeted antibody therapy
*RAS mutations confer resistance to this therapy
*bad prognosis
*Cetuximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the genetic mutations that you need to think about for Lung cancer?

A

EGFR/HER1
KRAS
EML4-ALK fusion (Inv(2))
*these are mutually exclusive and are done to predict EGFR targeted agents
*Gefitinib
*Erlotinib

31
Q

*Gefitinib and Erlotinib are what?

A

Lung cancer specific treatments
EGFR/HER1
KRAS
EML4-ALK fusion (Inv(2))
*these are mutually exclusive and are done to predict EGFR targeted agents
*Gefitinib
*Erlotinib

32
Q

Which of the three families of genetic mutations is the strongest predictor of EGFR inhibitor therapy RESISTANCE?

A

KRAS mutations (lung cancer, 30% of cases), strongly predict RESISTANCE to EGFR inhibitor therapy
*Gefitinib
*Erlotinib

33
Q

A smoker has lung cancer with mucinous histology. What is the most likely mutation?

A

KRAS mutation.
predicts lack of response to EGFR inhibitors

34
Q

A small % of lung cancers have an inversion. What’s the inversion, fusion, and why do we care?

A

EML4-ALK fusion (Inv(2))
these are in young, non-smokers with higher stage tumors and solid histology
*signet ring cells
*there is a specific treatment: Crizotinib

35
Q

Most common PTC mutation in children

A

RET-PTC1/3
*look for RET
*second most common in adults, but most common in kids
*10q (either inversion or translocation)

36
Q

Thyroid nodule, t(2;3)

A

PAX8-PPARy1
*less than half of follicular carcinomas
*think ‘follicular lesion’

37
Q

RAS mutations in thyroid

A

Follicular carcinoma
*more than half of follicular carcinomas

38
Q

RET mutation in thyroid

A

Activating RET mutations in MEDULLARY
*also, RET-PTC fusion in children for PTC
*most commonly sporadic (70% of cases), with the remaining 30% of cases being arising in patients with multiple endocrine neoplasia type 2 (MEN2)

39
Q

Clear cell renal cell carcinoma cytogenetics

A

3p deletion
*results in de-regulation of VHL gene
*de-regulation of ubiquitin pathway
*in 70% of sporadic CCRCC

40
Q

t(X;17)

A

translocation associated RCC (stain for TFE)
ASPL-TFE3
*papillary with psammoma bodies

41
Q

t(X;1)

A

translocation associated RCC (stain for TFE)
EITHER:
*PSF-TFE3
*PRCC-TFE3
*papillary with psammoma bodies

42
Q

t(6;11)

A

translocation associated RCC
Alpha-TFEB
*NOT papillary, NO psammoma bodies
*eosinophilic, younger patients, nests, tubules

43
Q

BRAF in melanoma

A

NOT in mucosal melanomas
most common mutation overall, found in skin melanomas
*target of directed therapy

44
Q

you see NUT and you think…

A

Head and neck
midline carcinoma, next to respiratory tract (including mediastinum) in children and young people that is fatal and ugly
*BRD4-NUT
*BRD3-NUT

45
Q

t(15;19)

A

BRD4-NUT
NUT midline carcinoma
*midline carcinoma, next to respiratory tract (including mediastinum) in children and young people that is fatal and ugly

46
Q

t(9;15)

A

BRD3-NUT
*3 is less than 4, NUT is on 15
NUT midline carcinoma
*midline carcinoma, next to respiratory tract (including mediastinum) in children and young people that is fatal and ugly

47
Q

t(11;19)

A

MECT1-MAML2
mucoepidermoid carcinoma

48
Q

PLAG1

A

Pleomorphic adenoma
8q12

49
Q

FOXL2 mutation

A

Granulosa cell tumor
ADULT type
specific for this entity

50
Q

t(12;15)

A

ETV6-NTRK
*cellular CMN
*infantile fibrosarcoma
*secretory carcinoma of salivary gland and breast

51
Q

ETV6-NTRK

A

t(12;15)
*cellular CMN
*infantile fibrosarcoma
*secretory carcinoma of salivary gland and breast

52
Q

why is DSRCT in abdomen positive for WT1 IHC?

A

t(11;22)
EWS-WT1 fusion

53
Q

GYN case, t(7;17)

A

endometrial stromal sarcoma
JAZF1-JJAZ1

54
Q

PTEN for GYN tumors…

A

PTEN is one of the most frequently mutated genes in endometrioid adenocarcinoma

55
Q

DICER1 mutations in GYN tumors

A

sertoli leydig

56
Q

isochromosome 12p or 12p amplification

A

Dysgerminoma
*ovarian mass, young girl
*look for gonadoblastoma part with calcifications
*most common malignant germ cell tumor in ovary

57
Q

Hairy Cell Leukemia

A

*bone marrow fibrosis
*splenomegaly
*villi all around the cell
*fried egg bone marrow HandE
*monocytopenia
BRAV V600E and annexin POSITIVE
(vs splenic marginal zone, which is BRAF V600E NEGATIVE and annexin 1 negative)

58
Q

isochromosome 12p and testicular tumors

A

spertamotyic seminoma (3 cell types) is NOT isochromosome 12p associated
*normal seminoma IS i12p associated
*does not have ITGCN component, and is not mixed with other germ cell tumors

59
Q

Molecular of polymorphous adenocarcinoma salivary gland

A

OTHER HIGH YIELD POINTS
* Usually seen in elderly females and most common site is the palate
* Presents as an asymptomatic slow growing mass
* Gross: Well circumscribed, unencapsulated yellow or tan mass
* Prognosis excellent and has a low recurrence rate about 10%
* IHC: positive for cytokeratin, S100, SOX10, vimentin; variable p63; P40 (-)
* Molecular: Activating hotspot mutations in PRKD1 in nearly 75% of cases

60
Q

genetics of anaplastic thyroid carcinoma

A

p53 and TERT
*From a genetic perspective, inactivating mutations in TP53 are considered a hallmark of anaplastic carcinoma, and reported in most cases.
*TERT promoter mutations are also present in up to 73% of anaplastic carcinomas.

61
Q

infantile hemangioma

A

glut1
*present at birth
*rapid phase of growth, then slow involution
always has glut1

62
Q

t(11;19) (q21;p13)

A

chimeric CRTC1-MAML2 fusion gene
*mucoep

63
Q

t(12;15) (p13;q25)

A

ETV6-NTRK3 chimeric gene.
This translocation is considered a defining feature of mammary analogue secretory carcinoma.

64
Q

sinonasal papilloma molecular

A

(classic inverted type)
RNA in situ hybridization: Positive for low-risk HPV6/11
* Molecular:
➢ More than 90% of cases will have a somatic EGFR Exon 20 mutation
*oncocytic has KRAS mutations
*exophytic type still has HPV association, but LACKS the egfr and kras mutations

65
Q

sinonasal papilloma differential

A

exophytic is best prognosis and midline
the other two (oncocytic and inverted) are lateral or sinuses and have some risk of malignant transformation
*TP53 mutations portend malignant transmoration
*there is some association with low risk HPVs

66
Q

Dysembryoblastic neuroepthelial tumor molecular

A

FGR1 activating mutations
*overlying cortical dysplasia
*neurons floating in mucin
*columns of small tumor cells perpendicular to cortical surface
*olig2 IHC

67
Q

Pleomorphic xanthoastrocytoma, pilocytic astrocytoma and ganglioneuroma have what mutation in common?

A

BRAF V600E (MAPK pathway)
*if not that they have CDKN2A homozygoous deletions

68
Q

Pleomorphic xanthoastrocytoma

A

grade 2,3 (5 mitoses cutoff)
*kids in temporal lobe
*pleomorphic cells but still eosinophilic granular bodies
dense reticulin network

69
Q

Pilocytic astrocytoma most common fusion

A

A tandem duplication at 7q34 leading to a fusion between the poorly characterized gene KIAA1549 and BRAF is common and found in approximately 66% of pilocytic astrocytomas.
(MAPK pathway)
*most common glioma in kids, cerebellum
*midline structures like optic pathway? –> NF1

70
Q

BAP 1 loss meningioma

A

grade 3
*BAD

71
Q

grading criteria meningioma

A

Grade 2: more than 4 mit/HPF,
*3 or more FEATURES: (sheet-like growth, small cell change, big nucleoli, necrosis, increased cellularity)
*clear cell type (SMARCE1)
*chordoid type
Grade 3: any more than 20 mit/HPF
*anaplastic histology (sarcomatoid, carcinomatous, atypical mitoses)
*TERT promoter mutation
*CDKN2A homozygous deletion
*papillary subtype
*rahabdoid subtype (look for BAP1 loss)

72
Q

PBRM1 in meningioma

A

papillary subtype, grade 3 by definition

73
Q

CDKN2A deletion in meningioma

A

grade three
*BAD

74
Q

4 and 20 mits/HPF in the world of neuropath…

A

meningioma criteria, 1-2 and then 3-4

Anatomic Pathology Board Review (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions